Literature DB >> 6254570

Purified proenzyme C1r. Some characteristics of its activation and subsequent proteolytic cleavage.

G J Arlaud, C L Villiers, S Chesne, M G Colomb.   

Abstract

1. Upon incubation for 1 h at 37 degrees C, proenzymic C1r was activated by a proteolytic cleavage comparable to that observed in vivo; after reduction and alkylation, two fragments of apparent molecular weights 57 000 and 35 000 were evident on sodium dodecyl sulphate (SDS)-polyacrylamide gel electrophoresis. The activation kinetics were slightly sigmoidal and nearly independent of C1r concentration. They were characterized by a marked thermal dependence (activation energy = 45 kcal/mol). The reaction was inhibited by calcium and p-nitrophenyl-p'-guanidinobenzoate, but poorly sensitive to di-isopropyl phosphorofluoridate. The dependence of the activation rate on pH was unusual; it decreased progressively in the acid range (pH 4.5-6.5) which coincides with the dissociation of the C1r-C1r dimer. Above pH 6.5, the rate increased slightly and showed no clear maximum. These results are consistent with an intramolecular autocatalytic activation mechanism involving the pro-site of each subunit of the C1r-C1r dimer. 2. During a 5 h incubation period at 37 degrees C, C1r underwent two proteolytic cleavages which led to the successive removal of two fragments, alpha (35 000) and beta (7000-11 000) from each subunit, leaving a dimeric molecule of reduced size (Mr = 110 000; s20,w = 6.1 S). The proteolytic process was nearly independent of C1r concentration and characterized by a pH optimum at 8.5-9.0, and a high activation energy (36.8 kcal/mol). Calcium and p-nitrophenyl-p'-guanidinobenzoate, and also di-isopropyl phosphorofluoridate and benzamidine were inhibitors of this reaction. The product, C1r II, retained the original antigenic properties of C1r and a functional active site, but lost the capacity to bind C1s. These results are consistent with an autocatalytic intramolecular proteolysis mediated by the active site of each subunit of the C1r-C1r dimer.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6254570     DOI: 10.1016/0005-2744(80)90269-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  27 in total

Review 1.  Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent.

Authors:  Allen P Kaplan; Kusumam Joseph
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 8.667

2.  The quaternary structure in solution of human complement subcomponent C1r2C1s2.

Authors:  S J Perkins; A S Nealis
Journal:  Biochem J       Date:  1989-10-15       Impact factor: 3.857

3.  Isolation and functional characterization of the proenzyme form of the catalytic domains of human C1r.

Authors:  M B Lacroix; C A Aude; G J Arlaud; M G Colomb
Journal:  Biochem J       Date:  1989-02-01       Impact factor: 3.857

4.  Cloning and sequencing of full-length cDNA encoding the precursor of human complement component C1r.

Authors:  A Journet; M Tosi
Journal:  Biochem J       Date:  1986-12-15       Impact factor: 3.857

5.  Domain structure and associated functions of subcomponents C1r and C1s of the first component of human complement.

Authors:  C L Villiers; G J Arlaud; M G Colomb
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

6.  Characteristics of complement subcomponents C1r and C1s synthesized by Hep G2 cells.

Authors:  A Reboul; J C Bensa; M G Colomb
Journal:  Biochem J       Date:  1986-01-15       Impact factor: 3.857

7.  Studies on the interactions between C-reactive protein and complement proteins.

Authors:  Adrienn Bíró; Zita Rovó; Diana Papp; László Cervenak; Lilian Varga; George Füst; Nicole M Thielens; Gérard J Arlaud; Zoltán Prohászka
Journal:  Immunology       Date:  2007-01-18       Impact factor: 7.397

8.  Characterization of the C1q receptor on a human macrophage cell line, U937.

Authors:  J Arvieux; A Reboul; J C Bensa; M G Colomb
Journal:  Biochem J       Date:  1984-03-01       Impact factor: 3.857

9.  Fluid-phase interaction of C1 inhibitor (C1 Inh) and the subcomponents C1r and C1s of the first component of complement, C1.

Authors:  S Chesne; C L Villiers; G J Arlaud; M B Lacroix; M G Colomb
Journal:  Biochem J       Date:  1982-01-01       Impact factor: 3.857

10.  The catalytic chain of human complement subcomponent C1r. Purification and N-terminal amino acid sequences of the major cyanogen bromide-cleavage fragments.

Authors:  G J Arlaud; J Gagnon; R R Porter
Journal:  Biochem J       Date:  1982-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.